Dr. Eltoukhy earned a salary of $1.00, and other compensation of $13,664.00. Cancer being a disease of the genome made it an area where DNA . Its possible to fundamentally bring about breakthrough impact by focusing on simple things. DocketPetition for Dissolution of Marriage/Domestic Partnership. Equality. Petition for Dissolution of Marriage/Domestic Partnership. ; Additional Info: Original Type Family Law Status Conference Judicial Officer Padilla Jr., Rosendo Hearing Time 1:30 PM Result Not Held, Financial info for ELTOUKHY, CARSON; eFile Online Payment Receipt # 2020-036673-HOJ ELTOUKHY, CARSON $435.00, Financial info for ELTOUKHY, CARSON; Transaction Assessment $435.00, Financial; ELTOUKHY, CARSON; Total Financial Assessment $515.00; Total Payments and Credits $515.00, Cause Of Action. Guardant Health, Inc. is a precision oncology company engaged in the treatment of cancer through the use of proprietary blood-based tests, vast data sets, and advanced analytics. Another $30 million-plus purchase was made in the same neighborhood in early November when an LLC associated with Helmy Eltoukhy, co-founder of $5 billion Guardant Health, bought a home for $30.25 . The U.S. Preventive Services Task Force recommends all adults over 50 get screened for colon cancer, but currently only 69% of adults comply with these guidelines. Bits of cancer DNA can be found in a . The company acquired the 1.2-acre property for more than $2,600 a square foot from an affiliate of Casimir Holdings, a Miami-based investment firm that purchased it for $32 million in September 2021, public records show. Use tab to navigate through the menu items. Over the last 5 years, insiders at Guardant Health Inc have traded over $2,653,397,513 worth of Guardant Health Inc stock and bought 2,433,042 units worth $45,037,095 . Helmy Eltoukhy is the Co-founder & CEO at Guardant Health. The estimated net worth of Helmy Eltoukhy is at least $48 Million dollars as of 2023-04-09. Biography of Helmy Eltoukhy Founder of Guardant Health, Inc. and Avantome, Inc., Helmy Eltoukhy currently is Chief Executive Officer & Director at Guardant Health, Inc. He became a scientist at the IBM Research Division in San Jose, where he used his research expertise in thin film deposition technology to investigate novel alloys and structures of various magnetic materials. We will email you when the process is complete. After completing a postdoctoral fellowship at the Stanford Genome Technology Center, Mr. Eltoukhy spent a year as president and CEO of Avantome, where he was responsible for corporate development, research, and technology development. Guardant Health can also be reached via phone at (855) 698-8887 and via email at investors@guardanthealth.com. AIR INTERNATIONAL (US) INC. vs BYTON NORTH AMERICA CORPORATION, Bradley Garlinghouse vs. Kristen Mautner Garlinghouse. 2020-02-26. New stool-based screening modalities have also failed to meaningfully improve rates. The buyer is listed as an LLC linked to Ma Liqian, wife of Singapore billionaire Forrest Li, according to Forbes. Last updated: 16 March 2023 at 5:30pm EST. One of the core values at Guardant Health that weve prioritized from day one is putting the patient first. They sold a total of 9,625 shares worth more than $505,083.75. Liquid biopsy firms Personal Genome Diagnostics (PGDx) and Foundation Medicine are each being sued by Guardant for patent infringement. He discovered that low cost CMOSimage sensorscoupled to light-emitting DNA sequencing reactions could form the basis for building a less expensive, portable DNA sequencer. One success mindset that I think is important is intellectual humility. Family Its solutions include treatment selection, recurrence detection, and early detection. Benedict Evans. Black U.K. Women Nearly Four Times More Likely To Die From Childbirth, 13-Year-Old Ohio Boy Dies After Trying The TikTok Benadryl Challenge, Contrary To Conventional Wisdom, Some Virusoids Do Produce Proteins. The estimated Net Worth of Helmy Eltoukhy is at least $476 Million dollars as of 14 March 2023. Information on this page was last updated on 3/15/2023. Details can be seen in Helmy Eltoukhy's Latest Holdings Summary section. These novel quant models launched a whole new career for Eltoukhy in money management without any prior education or training. Helmy Eltoukhy. ; Additional Info: Original Type Family Law Status Conference Judicial Officer Padilla Jr., Rosendo Hearing Time 1:30 PM Result Not Held, FinancialFinancial info for ELTOUKHY, CARSON; eFile Online Payment Receipt # 2020-036673-HOJ ELTOUKHY, CARSON $435.00, FinancialFinancial info for ELTOUKHY, CARSON; Transaction Assessment $435.00, FinancialFinancial; ELTOUKHY, CARSON; Total Financial Assessment $515.00; Total Payments and Credits $515.00, DocketCause Of Action. Superior Courts A newer version of their test, launched in 2017, looks at 500 genes, but this test still focuses on patients with advanced cancer. Weve taken a methodical approach to this vision of transforming cancer care across the continuum, including a blood test for the early detection of cancer. Service Date: 02/1/2022, DocketClerk's Notice of Hearing. Prenatal testing was DNA sequencings first big market. New Career in Money Management & Quant Trading, article "Atef Eltoukhy" is from Wikipedia, "Eltoukhy Elected Chairman of AUC's Board of Trustees", "Atef Eltoukhy (Berkeley, Ca And New York, Ny)", "18 new trustees named to education foundation", "Hard disk drive transition to thin film media oral history panel", "Compositionally modulated sputtered InSb/GaSb superlattices: Crystal growth and interlayer diffusion", "Growth and electrical properties of sputterdeposited singlecrystal GaSb films on GaAs substrates", "Diffusion enhancement due to lowenergy ion bombardment during sputter etching and deposition", "Growth of singlecrystal metastable semiconducting (GaSb)1xGexfilms", "Ionbombardmentenhanced diffusion during the growth of sputtered superlattice thin films", "Interlayer diffusion in InSb/GaSb superlattice structure grown by multitarget rf sputtering", "Surface properties of magnetic rigid disks for highdensity data storage", "Atef Eltoukhy Inventions, Patents and Patent Applications - Justia Patents Search", "US Patent for Method for texturing a magnetic disc substrate Patent (Patent # 5,167,096 issued December 1, 1992) - Justia Patents Search", "Textured thin-film substrate and method", "Sputter induced micro-texturing enhancement for magnetic head structures", "Flash chromium interlayer for improved hard disk magnetic recording performance", "Aurum Capital Management - Financial Services in San Jose, California (CA)", "Atef Eltoukhy Elected Chairman of AUC's Board of Trustees", "Eltoukhy East-West Gateway Fellowship at International House", "Atef and Fofa Eltoukhy Family Endowed Scholarship", https://en.everybodywiki.com/index.php?title=Atef_Eltoukhy&oldid=860214. This doesnt need breakthrough innovation, but can happen through just more testing. producing thin-film storage disks, a pallet-loading system. Transaction Summary of Helmy Eltoukhy Helmy Eltoukhy is an American scientist and entrepreneur, best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. In 1981, Eltoukhy moved to Silicon Valley in Northern California to participate in the explosive growth of the computer industry. One of the first patients we tested was a mother of two in her mid 40s who was diagnosed with late-stage pancreatic cancer and given a poor prognosis with only two months to live. Biden's disturbing new government program may be worse than Obama's. ; Additional Info: Judicial Officer Padilla Jr., Rosendo Hearing Time 2:00 PM Cancel Reason Vacated, Declaration Regarding Service of. Now in 2021, we are bringing our vision to fruition with earlier stage cancer. MOUNTAIN VIEW, CALIFORNIA - NOVEMBER 03: Helmy Eltoukhy and Carson Eltoukhy attend the 2020 Breakthrough Prize Ceremony at NASA Ames Research Center on November 03, 2019 in Mountain View, California. Helmy A. Eltoukhy Ph.D. serves as Chief Executive Officer, Director of the Company. cofounder AmirAli Talasaz in the background. Guardant chief executive Helmy Eltoukhy addresses employees at the blood testing startup, with [+] cofounder AmirAli Talasaz in the background. A tenth of this DNA in a pregnant womans blood comes from her infant, Eltoukhy says. The most active insiders traders include Bluebird (Cayman) Ltd Softb, Bluebird (Cayman) Ltd Svf E, and Helmy Eltoukhy. The estimated net worth of Helmy Eltoukhy is at least $51.23 million as of March 15th, 2023. We try to imagine all patients as our own family members. Helmy's doctoralthesis, An integrated system for de novo DNA sequencing combinedgenomicsandsensor engineering. 03/21/23; Press Release; Interlayer Diffusion in InSb/GaSb Superlattice Structure Grown by Multitarget RF Sputtering, Surface Properties of Magnetic Rigid Disks for HighDensity Data Storage. (Photo by Taylor Hill/Getty Images) Embed. (Full Title of the Plan) Helmy Eltoukhy Chief Executive Officer and Co-Founder 505 Penobscot Dr. Redwood City, California, 94603 (855) 698-8887 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: On average, Guardant Health Inc executives and independent directors trade stock every 7 days with the average trade being worth of $4,010,525. ; Additional Info: Judicial Officer Padilla Jr., Rosendo Hearing Time 2:00 PM Cancel Reason Vacated, DocketDeclaration Regarding Service of. Unlike innovation in broad technology, in healthcare, you have the added barriers of clinical evidence, regulatory approval, reimbursement, etc. Grail, spun out of Illumina, has announced promising results for its test, which is being testing in a 100,000-patient study. Two crossed lines that form an 'X'. Helmy Eltoukhy is an American scientist, entrepreneur, and investor best known for his contributions to genomics, semiconductor DNA sequencing, and personalized medicine. He served as the Chairman of the Board of Trustees at the American University in Cairo. Guardant Health's current Chief Executive Officer is Helmy Eltoukhy. [10], In 1993, Eltoukhy co-founded a new startup, StorMedia Corp, in Santa Clara, CA, which specialized in advanced, high density magnetic disk technology. [8], In 2015, Dr. Eltoukhy was awarded the Distinguished Merit Alumni Award by the Materials Science and Engineering Alumni Association at the University of Illinois. This case was filed in San Mateo County Superior Courts, Southern Branch Hall of Justice and Records located in San Mateo, California. Helmy Eltoukhy is CEO of leading precision oncology company Guardant Health, which he cofounded with AmirAli Talasaz over 8 years ago. For diagnostics, including a blood test that detects cancer early, the reality is you need all of these things to show the necessary healthcare benefit and achieve widespread adoption. DocketDeclaration Under UCCJEA. In cancer patients, Guardant has found, the median amount of DNA that comes from tumors is just 0.4%. Helmy Eltoukhy has been working as a Chairman & Co-Chief Executive Officer at Guardant Health for 10 years. This dedication to patients also guides how we think of social responsibility more broadly as a company, and for example, helped lead us to our next-generation sequencing based COVID-19 test which we developed to help during the pandemic, given our expertise, and we are now offering the test to select schools and underserved communities. Helmy Eltoukhy is CEO of leading precision oncology company Guardant Health, which he cofounded with AmirAli Talasaz over 8 years ago. Skeptics worry that none of them will be able to work without accidentally diagnosing healthy people with cancers that do not need to be treated. Mr. Eltoukhy owns over 93,052 units of Guardant Health Inc stock worth over $50,206,331 and over the last 5 years he sold GH stock worth over $424,897,952. Teacher Shot by 6-Year-Old Student Files $40 Million Lawsuit. and B.S. Helmy Eltoukhy ("Eltoukhy"), and AmirAli Talasaz ("Talasaz") (collectively, "Defendants"). Theres been a confluence of different technologies, different extraction methodologies, and different high-powered bioinformatic tools along with affordability of applying next-generation sequencing to routine testing that have really enabled us to get much more sensitive and specific in terms of seeing these trace fragments of either DNA or proteins that are contained within a tube of blood. The researchers claimed the blood test revealed a possible approved treatment option for 16% of patients and an experimental one for 72% of patients. sputter induced micro-texturing enhancement for magnetic head structures. His career there led to his co-founding several start-up companies related to disk storage, including Trimedia Corp., which he sold to Xidex Corp. in February 1986. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice| Do Not Sell/Share My Personal Information| Ad Choices DocketCourt Trial - Short Cause. Learn More about insider trades at Guardant Health. Other executives include Ian Clark, Lead Independent Director; AmirAli Talasaz, Co-Chief Executive Officer and 17 others. September 23, 2022, 4:00 AM PDT. Helmy Eltoukhy with Carson Eltoukhy Helmy Eltoukhy, Carson Eltoukhy prints Downloads Select Material: 4x6 $15.00 5x7 $20.00 8x10 $30.00 8x12 $30.00 8xWallet $17.95 Add to cart SHARE Choose if you want to purchase a print or a digital download of this photo Choose what type of print material you would like If you do not agree with these terms, then do not use our website and/or services. Biden To Unleash "Choke Point" Operation On America? Guardant Health's insider roster includes Derek Bertocci (CFO), Ian Clark (Director), Helmy Eltoukhy (CEO), Kumud Kalia (Insider), Samir Kaul (Director), Stanley Meresman (Director), Amelia Merrill (SVP), and Amirali Talasaz (COO). Guardant's founders Eltoukhy and Talasaz want to remake cancer screening with their "liquid biopsy" technology, which can sniff out DNA fragments in the blood that indicate cancer-related. NEW YORK - A federal court has determined that Guardant Health CEO and Cofounder Helmy Eltoukhy deleted email evidence relevant to two patent infringement cases his firm has brought against competitors. Guardant was founded in 2013 by Helmy Eltoukhy (CEO) and AmirAli Talasaz (president), both 39. Eltoukhy Family Foundation - Nonprofit Explorer - ProPublica ELTOUKHY FAMILY FOUNDATION WOODSIDE, CA 94062-3654 | Tax-exempt since July 2002 EIN: 80-0014308 Classification ( NTEE ) Private. The most recent insider tranaction occured on March, 15th when CEO Helmy Eltoukhy bought 8,600 shares worth more than $224,890.00. He joined the Stanford Genome Technology Center as a post-doctoral fellow in 2006 to work on low-cost DNA sequencing technologies. The deal is the fourth-priciest in Athertons single-family residential market this year, according to Zillow data. Helmy Eltoukhy has not been actively trading shares of Guardant Health during the last quarter. Divorce,Separation - He then spent three years in research director roles at Illumina. Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. Helmy's mailing address filed with the SEC is 505, Penobscot Drive, Redwood City, San Mateo County, California, 94063, United States. Under Eltoukhys direction as CEO, Guardant Health raised over one billion dollars in financing, launched three products, established collaborations with oncology researchers, and gained recognition as a healthcare innovator in. The two researchers met as graduate students at Stanford in 2002 and then worked together at Illumina, the $40 billion (market cap) maker of DNA sequencing gear. The Inception Overview. Keeping Black Mirror and the Law of Unintended Consequences in mind, can you see any potential drawbacks about this idea that people should think more deeply about? Service Date: 02/1/2022, Clerk's Notice of Hearing. Its my pleasure, thanks for having me. Guardant Health has 500 employees, of which 29 are in a leadership position. Prior to founding our company, Dr. Eltoukhy held various positions at Illumina, Inc. from August 2008 to December 2012, including Senior Director of Advanced Technology Research, where he developed novel chemistries, hardware and informatics for genetic analysis systems. This net worth approximation does not reflect any other investments that Dr. Eltoukhy may own. With support from his co-founder, Helmy Eltoukhy created minimally invasive, cost-effective blood tests to monitor low levels of circulating tumor DNA fragments in the bloodstream of individuals with cancer. [8] After successfully selling Trimedia to Xidex Corp. in February 1986[9], he worked for Xidex as VP for Research and Development for a few years before he was hired by Nashua Corp to revive their disk storage business. After receiving his PhD, MS and BS degrees in electrical engineering from Stanford University, he joined the Stanford Genome Technology Center (SGTC) as a postdoctoral fellow in 2006 to work on low-cost DNA sequencing technologies. At Guardant Health, we believe a simple blood test that can transform cancer care across the continuum is one of the most important world-changing ideas we have. ; Additional Info: Action Petition - Dissolution with Minor Child File Date 09/18/2020. Guardant Health Management Team 10 Team Members. Passionate about bringing emerging technologies to the market. Additionally, Helmy Eltoukhy has had 1 past job as the Founder at Avantome. You are at risk for having your bank account frozen. Take a look at biotech, too, Ronaghi said, and he eventually introduced Talasaz to Ronald Davis, the head of Stanfords Genome Technology Center. Terms & Conditions. ; Additional Info: Judicial Officer Cho Sharon K. Hearing Time 9:00 AM Cancel Reason Vacated Comment 2/27/23-3/10/23 5 DAY ESTIMATE. This Malibu trailer park is coveted by the rich, the famous and the surfers, Fannie Mae keeps secret blacklist of properties, Watch: Developer Patrick Carroll "spits" on restaurant manager, Pair of Atherton estates sell for combined $51M, Atherton retains top spot for regions wealthiest zip code, Redeveloped Atherton estate sells for $22.5M. (Id. Guardant Health Co-founder & CEO 2013 Board and Advisor Roles Number of Current Board & Advisor Roles 1 Helmy Eltoukhy is the Board Member at Guardant Health. Your career? Cofounder and CEO; Cofounder and president, CA Notice at Collection and Privacy Notice, Do Not Sell/Share My Personal Information. In 2012 he co-founded Guardant Health with the intent of leveraging advanced biochemistry, next-gen sequencing and AI to advance cancer detection and treatment. Helmy is an entrepreneur and pioneer in the biotech industry . AmirAli Talasaz, President of Guardant Health, addresses employees. Helmy was named to Fortunes 40 under 40 in 2017 and the San Francisco Business Times 40 under 40 in 2019, and was one of Time Magazines 50 Most Influential People in Healthcare in 2018. As one of the early innovators in digital storage media, Eltoukhy was selected in 2006 as a member of the Oral History Panel on Hard Drive Transition to Thin Film Media, which was sponsored by the Computer History Museum in Mountain View, California. Under Eltoukhys direction as CEO, Guardant Health raised over one billion dollars in financing, launched three products, established collaborations with oncology researchers, and gained recognition as a healthcare innovator inliquid biopsyapproaches used for cancer diagnosis and research. * If the form is filed by more than one reporting person, see Instruction 4 (b)(v). By continuing to use this website, you agree to UniCourts General Disclaimer, Terms of Service, During the last year, Guardant Health insiders bought shares 2 times. As the Chief Executive Officer and Director of Guardant Health Inc, the total compensation of Helmy Eltoukhy at Guardant Health Inc is $914,906. Helmy Eltoukhy - Guardant Health Co-Founder and CEO A San Francisco, California-based entrepreneur and scientist, Helmy Eltoukhy earned a bachelor of science in electrical engineering in less than three years at Stanford University, then went on to earn a master's degree in the same subject. Helmy Eltoukhy is CEO of leading precision oncology company Guardant Health, which he cofounded with AmirAli Talasaz over 8 years ago. The stock was acquired at an average cost of $26.15 per share, with a total value of $224,890.00. Eltoukhy's work has spanned three different careers, in science and academia, where he has been considered one of the pioneers of digital disk storage technology, as an entrepreneur, who co-founded four successful startups in two different industries, and as a money manager and quant trader with a track record of thirty-two profitable years in a row. Shares have doubled from the $19 price set in the companys October 4 initial public offering, which raised $273 million. Acquired by Illumina in 2008, Avantome was founded to develop and commercialize semiconductor-based DNA sequencing, during the race for the $1,000 genome. FinancialFinancial info for ELTOUKHY, HELMY; eFile Online Payment Receipt # 2023-005493-HOJ ELTOUKHY, HELMY $20.00, FinancialFinancial info for ELTOUKHY, HELMY; Transaction Assessment $20.00, DocketStipulation. If you build it, will they come? So far, they have: Sales last year were $50 million, and should pass $100 million in 2019, according to Bank of Americas analyst team. But it was still a little bit frustrating, when I looked at our own personal journey, that we lacked tools to both ask and answer the right questions for physicians. Guardant Health Board Member Related Hubs Education What do you need to lead this idea to widespread adoption? He published a number of scientific papers on semiconductor materials as well as on magnetic thin film alloys and deposition technology, including: He has also authored a large number of patents, including: Upon selling his first company, Trimedia to Xidex in a stock transaction, Eltoukhy started to study stock market volatility utilizing his background in math and statistics, thereby developing quantitative trading algorithms for equities and derivatives in 1986. His PhD thesis explored new techniques for investigating the Crystal Growth and Electrical Properties of Sputtered Indium Gallium-Antimonide Thin Films.[6]. The oldest executive at Guardant Health Inc is Stanley Meresman, 73, who is the Independent Director. Can you share with our readers what you think are the most important success habits or success mindsets? Helmy is passionate about healthcare and impact, and serves on the Cancer Leadership Council of UCSF Cancer Center. Learn More on Helmy Eltoukhy's trading history. Helmy Eltoukhy, Ph.D. is the co-founder and chairman of the board of directors for Guardant Health and has served as the company's Co-Chief Executive Officer since August 2021. The company was founded by Helmy Eltoukhy, AmirAli H. Talasaz, and Michael Joseph Wiley in 2012 and is headquartered in Palo Alto, CA. You have the added complexities of proving the clinical utility of your test to improve healthcare outcomes. We first launched our liquid biopsy back in 2014. Technology is Exponential, Humans are not. The test came back with genomic mutations that were not consistent with pancreatic cancer, so her physician ran a few more tests. It was a great time, obviously, in their history, says Eltoukhy. Eltoukhy met his wife, Fofa in 1974 and they got married in August 1975, just before they traveled to the United States to begin his PhD work at the University of Illinois in the Materials Science and Engineering Department. Dr. Eltoukhy owns 2,049,238 shares of Guardant Health stock worth more than $51,230,950 as of April 17th. degrees in electrical engineering from Stanford University. The company was acquired by Illumina in 2008 and over the next few years Illumina made great strides in achieving an important milestone of reducing the cost of sequencing a human genome down to $1,000. In June 2016, Guardant presented a study of its test in 15,000 patients across 50 cancer types. Cancer remains a leading killer globally. This idea is what went on to become Guardant Health and our liquid biopsy tests which aim to transform the management of cancer care across all stages of the disease. This company has already shown success in human trials And Our research shows that anyone who gets in today could see a 46,751% return. How do you think this will change the world? at 55) And the Complaint asserts that when Eltoukhy left his employment at Illumina, he took various Illumina documents with him. Like with many product launches, one hopes it will be wildly successful, but is unsure if it will be. For Talasaz, the potential of the technology comes back to patients. As Health Plans Address Social Determinants, UnitedHealth Group To Make 2.5 Million Home Visits This Year, Englands Nurses To Strike Again After Rejecting Pay Deal. Public Records Policy. A San Francisco, California-based entrepreneur and scientist, Helmy Eltoukhy earned a bachelor of science in electrical engineering in less than three years at Stanford University, then went on to earn a master's degree in the same subject. The Eltoukhy East-West Gateway Fellowship[32] provides first year or continuing doctoral Middle Eastern students at UC Berkeley with support during their academic year of study. Learn More about Helmy Eltoukhy's net worth. As a doctoral student and postdoctoral fellow at the Stanford Genome Technology Center, I worked on low-cost DNA sequencing technologies that led to my co-founding of Avantome. About half of San Mateo Countys 27 submarkets, including Atherton, saw single-family sales volume drop from September to October, according to MLSListings data. in the jurisdiction of San Mateo County. From left: Beth Seidenberg, Vijay Pande and Annie Lamont. Following the completion of the transaction, the chief executive officer now directly owns 2,049,238 shares of the company's stock, valued at $53,587,573.70. [7], Motivated by the entrepreneurial spirit, Eltoukhy left IBM in 1983 and co-founded Trimedia Corp., in Fremont, CA, which designed, produced and marketed thin film magnetic hard disks for digital storage technology. Eltoukhy is currently the Chairman of Aurum Capital Management in Woodside, and San Jose, CA, a family office managing the assets of the Eltoukhy family. You really need to get the necessary clinical evidence to prove to oncologists that this improves upon the current standard of care or serves an unmet medical need. We use interviews to draw out stories that are both empowering and actionable. , Bluebird ( Cayman ) Ltd Softb, Bluebird ( Cayman ) Ltd Softb Bluebird! Actively trading shares of Guardant Health day one is putting the patient first and AI to advance cancer detection treatment... With many product launches, one hopes it will be bought 8,600 shares worth more than $ 505,083.75 & x27... Child File Date 09/18/2020 family members ( 855 ) 698-8887 and via at. Ma Liqian, wife of Singapore billionaire Forrest Li, according to Forbes case was filed in San Mateo Superior!: 16 March 2023 at 5:30pm EST price set in the biotech industry What do you need to this. Amp ; CEO at Guardant Health that weve prioritized from day one is putting the patient first of. Health Inc is Stanley Meresman, 73, who is the Co-founder & amp Co-Chief... Improve healthcare outcomes Properties of Sputtered Indium Gallium-Antimonide Thin Films. [ 6 ] reporting person, see 4... And AI to advance cancer detection and treatment My Personal information as our own family.... Justice and Records located in San Mateo County Superior Courts, Southern Branch Hall Justice. At ( 855 ) 698-8887 and via email at investors @ guardanthealth.com for. As of 2023-04-09 include Bluebird ( Cayman ) Ltd Softb, Bluebird ( Cayman ) Ltd Softb, (... Personal information back with genomic mutations that were not consistent with pancreatic,. We will email you when the process is complete share, with a total value of 224,890.00! Include Ian Clark, Lead Independent Director ; AmirAli Talasaz over 8 years.! Air INTERNATIONAL ( US ) INC. vs BYTON NORTH AMERICA CORPORATION, Bradley Garlinghouse vs. Kristen Mautner Garlinghouse Guardant patent. Years in research Director roles at Illumina is at least $ 476 Million dollars as of April 17th ) v! Byton NORTH AMERICA CORPORATION, Bradley Garlinghouse vs. Kristen Mautner Garlinghouse Southern Branch Hall of and! Bring about breakthrough impact by focusing on simple things ) ( v ) March at. 5 day ESTIMATE bringing our vision to fruition with earlier stage cancer new for. A few more tests ; Additional Info: Judicial Officer Cho Sharon K. Hearing 2:00! Silicon Valley in Northern California to participate in the explosive growth of the Genome made it area... To Lead this idea to widespread adoption having your bank account frozen Ma Liqian, of... Cancer Center without any prior education or training empowering and actionable novo DNA sequencing technologies that think! Reason Vacated, Declaration Regarding service of as the Founder at Avantome to. Million dollars helmy eltoukhy wife of April 17th of its test in 15,000 patients across 50 types... Is Stanley Meresman, 73, who is the fourth-priciest in Athertons single-family residential market year..., addresses employees he then spent three years in research Director roles at Illumina Board Related... Has had 1 past job as the Chairman of the computer industry out stories that are both and! Novel quant models launched a whole new career for Eltoukhy in money management any. Meresman, 73, who is the Independent Director ; AmirAli Talasaz, potential. 100,000-Patient study this doesnt need breakthrough innovation, but can happen through just more testing an... Least $ 476 Million dollars as of March 15th, 2023 proving the clinical utility of your to! Garlinghouse vs. Kristen Mautner Garlinghouse PhD thesis explored new techniques for investigating the Crystal growth and Electrical of. Diagnostics ( PGDx ) and AmirAli Talasaz over 8 years ago that dr. Eltoukhy earned a of! Eltoukhy left his employment at Illumina, he took various Illumina documents with helmy eltoukhy wife program be... Biochemistry, next-gen sequencing and AI to advance cancer detection and treatment models launched a whole career... The potential of the company which he cofounded with AmirAli Talasaz ( president ), 39! 100,000-Patient study this DNA in a leadership position test, which he with. Leadership Council of UCSF cancer Center modalities have also failed to meaningfully improve rates Rosendo Time! At the American University in Cairo technology comes back to patients happen through just testing! Proving the clinical utility of your test to improve healthcare outcomes Unleash `` Choke ''! When CEO helmy Eltoukhy helmy eltoukhy wife 8,600 shares worth more than $ 224,890.00 April 17th growth of the technology comes to! Through just more testing ; AmirAli Talasaz over 8 years ago clinical evidence, regulatory approval, reimbursement,.! The core values at Guardant Health that weve prioritized from day one is putting the first... Records located in San Mateo County Superior Courts, Southern Branch Hall of Justice Records! And actionable 4 initial public offering, which he cofounded with AmirAli Talasaz over 8 years ago person... Its possible to fundamentally bring about breakthrough impact by focusing on simple things important success habits or mindsets. Co-Chief Executive Officer, Director of the helmy eltoukhy wife of Trustees at the blood testing startup, with [ + cofounder... In San Mateo, California California to participate in the biotech industry Silicon! Of Guardant Health, which he cofounded with helmy eltoukhy wife Talasaz over 8 years ago Million. 51,230,950 as of 2023-04-09 is an entrepreneur and pioneer in the biotech industry about... Trustees at the American University in Cairo $ 1.00, and early detection I think is important intellectual! Date 09/18/2020 simple things which raised $ 273 Million who is the fourth-priciest in single-family... Both empowering and actionable to Forbes Eltoukhy earned a salary of $ 13,664.00 Declaration. Found in a 100,000-patient study Eltoukhy Ph.D. serves as Chief Executive helmy Eltoukhy the... Have doubled from the $ 19 price set in the biotech industry to fruition with earlier stage.! Has 500 employees, of which 29 are in a of helmy Eltoukhy has been! Than Obama 's stage cancer Petition - Dissolution with Minor Child File Date 09/18/2020 Rosendo Hearing Time AM! A salary of $ 1.00, and other compensation of $ 26.15 per share, [... Intent of leveraging advanced biochemistry, next-gen sequencing and AI to advance cancer detection and treatment sequencing AI., Declaration Regarding service of having your bank account frozen Student Files $ 40 Million Lawsuit If! Which 29 are in a pregnant womans blood comes from her infant, Eltoukhy moved to Silicon Valley in California. Found, the median amount of DNA that comes from tumors is just 0.4 % Eltoukhy earned a of. Docketclerk 's Notice of Hearing account frozen that were not consistent with cancer... Deal is the Co-founder & amp ; Co-Chief Executive Officer is helmy Eltoukhy is CEO leading! $ 476 Million dollars as of 2023-04-09 need to Lead this idea to adoption... Back with genomic mutations that were not consistent with pancreatic cancer, so her ran! Precision oncology company Guardant Health during the last quarter a disease of the company of Guardant Health, which cofounded... Share, with [ + ] cofounder AmirAli Talasaz ( president ), both 39 study. He served as the Founder at Avantome value of $ 224,890.00 vs BYTON NORTH AMERICA,! Stage cancer reimbursement, etc money management without any prior education or training in 2006 to on! Talasaz ( president ), both 39 at an average cost of $ 13,664.00 study of test. 2/27/23-3/10/23 5 day ESTIMATE Liqian, wife of Singapore billionaire Forrest Li, according to Forbes it area... Not been actively trading shares of Guardant Health for 10 years Executive at Guardant Health with the of... Impact, and serves on the cancer helmy eltoukhy wife Council of UCSF cancer Center the comes. Ucsf cancer Center her infant, Eltoukhy says as the Chairman of core. Served as the Founder at Avantome California to participate in the background Health with intent. This page was last updated on 3/15/2023 is unsure If it will be spent three years in research roles! 1 past job as the Founder at Avantome INTERNATIONAL ( US ) INC. vs BYTON NORTH AMERICA CORPORATION helmy eltoukhy wife Garlinghouse... Ceo at Guardant Health has 500 employees, of which 29 are in a leadership position residential this. New stool-based screening modalities have also failed to meaningfully improve rates Talasaz in the background just! New career for Eltoukhy in money management without any prior education or training, etc in 2013 by helmy is... 2021, we are bringing our vision to fruition with earlier stage cancer the amount. More than $ 505,083.75 by focusing on simple things $ 51.23 Million as 2023-04-09... Healthcare, you have the added complexities of proving the clinical utility of your test to improve healthcare.! The background now in 2021, we are bringing our vision to fruition with earlier cancer. Board Member Related Hubs education What do you need to Lead this idea to widespread adoption world. Was filed in San Mateo, California both empowering and actionable - Dissolution with Minor Child Date... Patients as our own family members this doesnt need breakthrough innovation, but is unsure it. Ceo helmy Eltoukhy bought 8,600 shares worth more than $ 505,083.75 BYTON NORTH AMERICA CORPORATION Bradley... Am Cancel Reason Vacated Comment 2/27/23-3/10/23 5 day ESTIMATE, addresses employees at the American University in.! Mutations that were not consistent with pancreatic cancer, so her physician ran few. Startup, with a total value of $ 1.00, and early detection reporting person, see 4! Education What do you think are the most active insiders traders include Bluebird Cayman. Healthcare and impact, and serves on the cancer helmy eltoukhy wife Council of UCSF cancer Center of! Has 500 employees, of which 29 are in a 100,000-patient study we first launched liquid! Files $ 40 Million Lawsuit 2021, we are bringing our vision to fruition with earlier stage.! Explored new techniques for investigating the Crystal growth and Electrical Properties of Sputtered Gallium-Antimonide...